Guillain-Barr� Syndrome Market, Global Outlook and Forecast 2023-2029

Guillain-Barr� Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
This report aims to provide a comprehensive presentation of the global market for Guillain-Barr� Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guillain-Barr� Syndrome. This report contains market size and forecasts of Guillain-Barr� Syndrome in global, including the following market information:
Global Guillain-Barr� Syndrome Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Guillain-Barr� Syndrome market was valued at US$ 448.3 million in 2022 and is projected to reach US$ 539.5 million by 2029, at a CAGR of 2.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Intravenous Immunoglobulin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Guillain-Barr� Syndrome include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Guillain-Barr� Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Guillain-Barr� Syndrome Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Guillain-Barr� Syndrome Market Segment Percentages, by Type, 2022 (%)
    Intravenous Immunoglobulin
    Plasma Exchange
    Others
Global Guillain-Barr� Syndrome Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Guillain-Barr� Syndrome Market Segment Percentages, by Application, 2022 (%)
    Hospital Pharmacies
    Retail Pharmacies
    Others
Global Guillain-Barr� Syndrome Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Guillain-Barr� Syndrome Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Guillain-Barr� Syndrome revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Guillain-Barr� Syndrome revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Grifols
    CSL Behring
    Octapharma
    Nihon Pharmaceutical
    Akari Therapeutics
    China Biologic Products Holdings
    Biotest
    Kedrion
Outline of Major Chapters:
Chapter 1: Introduces the definition of Guillain-Barr� Syndrome, market overview.
Chapter 2: Global Guillain-Barr� Syndrome market size in revenue.
Chapter 3: Detailed analysis of Guillain-Barr� Syndrome company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Guillain-Barr� Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.